Belpointe Asset Management’s Cardiff Oncology CRDF Stock Holding History

Belpointe Asset Management’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$36.7K	Buy
2025 Q1	$36.5K	Buy
2023 Q2	–	Sell
2023 Q1	$18.9K	Buy
2022 Q4	$9.8K	Buy